CD274 and colorectal cancer: Blocking the interaction between PD-1 on immune effector cells and PD-L1 on tumor cells has been demonstrated to reverse the suppression of antitumor immunity and has revealed significant antitumor effects in different malignancies, including advanced colorectal cancer (CRC) (17).